Covered recipient · General Payments record
RICHARD DUNCAN MINKNER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,474.14
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $802.93 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $424.57 | 12 |
| IDORSIA PHARMACEUTICALS US INC | $130.85 | 2 |
| Novo Nordisk AS | $81.00 | 4 |
| DEXCOM, INC. | $76.36 | 3 |
| Exact Sciences Corporation | $31.51 | 2 |
| Abbott Laboratories | $24.37 | 1 |
| Amgen Inc. | $20.08 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.37 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124897485 | CMS |
| ABBVIE INC. | $102.23 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042590 | CMS |
| ABBVIE INC. | $21.32 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042592 | CMS |
| ABBVIE INC. | $27.93 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042594 | CMS |
| ABBVIE INC. | $83.62 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042596 | CMS |
| ABBVIE INC. | $16.65 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042598 | CMS |
| ABBVIE INC. | $34.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042600 | CMS |
| ABBVIE INC. | $19.36 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042602 | CMS |
| ABBVIE INC. | $24.72 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042604 | CMS |
| ABBVIE INC. | $35.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042606 | CMS |
| ABBVIE INC. | $28.80 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042608 | CMS |
| ABBVIE INC. | $15.26 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042610 | CMS |
| ABBVIE INC. | $15.68 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105042612 | CMS |
| Amgen Inc. | $20.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117631085 | CMS |
| Dexcom, Inc. | $36.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330853 | CMS |
| Dexcom, Inc. | $19.07 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330855 | CMS |
| Dexcom, Inc. | $20.36 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153330857 | CMS |
| Exact Sciences Corporation | $14.59 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114791072 | CMS |
| Exact Sciences Corporation | $16.92 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114791077 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $8.16 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146756095 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $122.69 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146783276 | CMS |
| Novo Nordisk Inc | $20.05 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097642062 | CMS |
| Novo Nordisk Inc | $23.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097752799 | CMS |
| Novo Nordisk Inc | $21.03 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097749875 | CMS |
| Novo Nordisk Inc | $16.92 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097309847 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.19 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144610649 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.